Industry Transformation
When most people think of veterinary healthcare, they picture routine pet checkups or emergency surgeries for companion animals. But that perspective no longer reflects the reality of the industry.
Veterinary healthcare today sits at the intersection of public health, food security, biotechnology, AI, sustainability, and global disease prevention.
More importantly, this transformation is not theoretical — it is being actively shaped by pharmaceutical companies, animal health leaders, agri-tech firms, and global health organizations making long-term strategic investments in the sector.
The veterinary industry is no longer operating as a peripheral healthcare category. It is increasingly being built, funded, and governed like a core global health industry.
The Market Shift
The scale of investment tells the story clearly. The global animal health market, valued at approximately $40.1 billion in 2025, is projected to reach $51.6 billion by 2034.
Broader veterinary healthcare estimates suggest the market could grow from $62.28 billion in 2025 to over $92 billion by 2031, driven by rising pet ownership, livestock health demands, preventive medicine, biologics, and AI-powered diagnostics.
Industry leaders are responding accordingly — treating veterinary healthcare not as a secondary medical category, but as a pharma-grade, high-growth strategic sector.
At the center of this shift is the growing recognition of the One Health framework: the understanding that human health, animal health, and environmental health are deeply interconnected.
Expanding Role
Veterinary healthcare now supports multiple global systems simultaneously:
- Public health and zoonotic disease prevention
- Food production and agricultural resilience
- Wildlife conservation and biodiversity protection
- Environmental sustainability
- Global trade and biosecurity
- AI-driven diagnostics and predictive healthcare
Reshaping Forces
The Forces Reshaping the Industry
2.1 The Pet Humanisation Megatrend
In developed markets, pets are increasingly viewed as family members, not property. This cultural shift has profound economic consequences. Pet owners are willing to spend significantly on diagnostics, surgery, chemotherapy, physiotherapy, and mental health services for their animals. Premium nutrition, wellness plans, and insurance products are seeing double-digit growth.
This shift is also reflected in growing demand for advanced companion animal care and pain management solutions
This trend is no longer confined to North America and Western Europe. Pet ownership in China grew by over 20% during the pandemic years. Brazil, India, and South Korea are all seeing rapidly expanding middle-class pet populations with rising healthcare expectations.
Similar trends are accelerating the companion animal market in the United States, highlighted in Rising Pet Adoption & Animal Health Market (US)
2.2 Food Security and Livestock Medicine
With a global population approaching 10 billion, the pressure on food systems is intensifying. Livestock represent a critical source of protein for billions of people, and diseases such as African Swine Fever, Avian Influenza, and Foot-and-Mouth Disease can devastate national agricultural sectors overnight.
Governments and corporations are investing heavily in preventive vaccines, diagnostics, and biosecurity protocols. The shift from reactive treatment to preventive and data-driven herd management is creating enormous opportunities for companies with strong research and regulatory capabilities.
2.3 One Health Framework
Perhaps the most significant structural development is the global adoption of the One Health framework — the recognition that human health, animal health, and ecosystem health are deeply interconnected. COVID-19, widely believed to have had zoonotic origins, powerfully illustrated this interdependency.
International bodies including the WHO, FAO, and the World Organisation for Animal Health (WOAH) are now coordinating veterinary and human health surveillance in ways that were unimaginable a decade ago. This has elevated veterinary medicine from an economic afterthought to a pillar of global health security.
2.4 Technology Disruption
Artificial intelligence, remote diagnostics, wearable biosensors, telemedicine, and genomics are transforming what is possible in veterinary care. Clinics can now offer diagnostic capabilities that previously required specialist referral. Farmers can monitor livestock health remotely.The growing adoption of monitoring technologies in clinical practice is further explored in Veterinary Perceptions of Animal Health Monitoring Technologies in Clinical Practice. Pet owners can consult a vet from their smartphone.
AI-powered veterinary intelligence solutions are helping organizations track digital transformation, diagnostic adoption, veterinary perceptions, and emerging animal health technologies across global markets.
These technologies are compressing the gap between human and veterinary medicine — and opening the door for technology companies and digital health platforms to enter the space.
3. Industry Evolution
How Industry Leaders Are Evolving
The strategic opportunity has not gone unnoticed by the world's most sophisticated companies. Below, we examine how the leading players across pharmaceuticals, diagnostics, clinical services, insurance, and technology are repositioning themselves.
Zoetis — Animal Health Powerhouse
Spun out of Pfizer in 2013, Zoetis has become the world's largest standalone animal health company, with revenues exceeding USD 9 billion in 2024.
Zoetis has moved aggressively into companion animal biologics — most notably with Librela and Solensia, the first monoclonal antibody treatments for osteoarthritis pain in dogs and cats.
EVOLUTION SNAPSHOT: Zoetis is transitioning from a vaccines and parasiticides business to a data-integrated animal health platform, building recurring revenue streams through diagnostics, digital tools, and innovative biologics.
IDEXX Laboratories — Diagnostics Leader
IDEXX has moved from selling diagnostic equipment to building a recurring revenue model anchored by cloud-connected instruments, software platforms, and reference laboratory networks embedded in tens of thousands of clinics worldwide.
Its SDMA test for early kidney disease detection enabled earlier diagnosis and treatment — improving outcomes while expanding the diagnostic market.
EVOLUTION SNAPSHOT: IDEXX is evolving from a diagnostics hardware company into a veterinary data and software ecosystem.
Mars Petcare — Veterinary Empire
Mars operates over 3,000 veterinary clinics across North America and Europe through Banfield, BluePearl, and VCA networks, building a vertically integrated pet health ecosystem from nutrition to diagnosis to treatment.
EVOLUTION SNAPSHOT: Mars Petcare is evolving from a pet nutrition company into a vertically integrated companion animal health platform.
Elanco — Growth Through M&A
Elanco's purchase of Bayer Animal Health expanded its portfolios. The company is focusing on parasiticides, pain management, dermatology, and sustainable livestock solutions.
EVOLUTION SNAPSHOT: Elanco is evolving into a focused, high-growth animal health company sharpening its portfolio around premium products.
Merck Animal Health — Innovation Leader
Merck leads in vaccines, aquaculture health, and companion animal parasiticides like Bravecto. The company invests in next-generation platforms including RNA-based vaccines.
EVOLUTION SNAPSHOT: Merck is evolving its R&D towards next-generation vaccine platforms and sustainable aquaculture health.
Emerging Tech Players
Vetster and Pawp telemedicine platforms, Antech digital pathology, Vetsource and Covetrus pharmacy management are capturing growing market share through digital innovation.
Global Impact
Beyond Pet Care: Global Significance
4. Private Equity Influx
Veterinary healthcare has attracted enormous private equity interest. NVA, VetCor, PetVet Care Centers, IVC Evidensia, and Medivet have built large networks. KEY TREND: PE groups are differentiating through specialty medicine, digital health, and emerging market expansion.
5. Geographies to Watch
Asia-Pacific (China, South Korea, Japan), Latin America (Brazil, Mexico), India, and Middle East/Africa represent high-growth opportunities driven by pet ownership, livestock operations, and food security investments.
Zoetis: Defining the Next Decade
CEO Kristin Peck: "Expand into new categories of care, advance next-generation therapies and define the industry's next decade." Zoetis identifies deepening human-animal bond, aging pet populations, medicalization of pet care, global protein demand, and chronic disease innovation as key drivers.
Global rollout of Vetscan OptiCell AI-enabled hematology analyzer signals the shift toward predictive, data-driven care models.
Strategic Challenges
6. Challenges to Navigate
Industry Consensus
Strategic Investment Themes
- Prevention Over Treatment: Early diagnostics, AI imaging, rapid PCR testing
- Biologics: Monoclonal antibodies, combination vaccines
- Antimicrobial Stewardship: Narrow-spectrum therapeutics, probiotics
- AI Platforms: Diagnostics, monitoring, telemedicine
- Emerging Markets: Asia-Pacific, Latin America expansion
Conclusion
A Strategic Sector for the Long Term
Veterinary healthcare has earned its place as a strategic global industry. The convergence of pet humanisation, food security imperatives, One Health awareness, and technological disruption has created a sector with the characteristics of a long-term structural growth story.
Not long ago, veterinary medicine was viewed largely as a local, fragmented service industry — neighbourhood clinics, farm calls, and occasional specialist referrals. Today, veterinary healthcare has evolved into a multi-billion-dollar strategic sector attracting private equity, pharmaceutical giants, diagnostic conglomerates, and technology companies from around the world.
The rapid evolution of veterinary intelligence platforms such as VetIntel360AI further highlights how data-driven insights and AI-powered research are becoming central to modern animal healthcare strategy.
Veterinary healthcare is no longer just about pets. It is now a strategic global industry influencing public health, food security, pandemic prevention, sustainability, biotechnology innovation, and economic resilience.
For investors, strategists, and entrepreneurs, the veterinary healthcare sector offers one of the most compelling intersections of purpose and commercial opportunity available today.
